Annual report pursuant to Section 13 and 15(d)

DESCRIPTION OF BUSINESS (Details Narrative)

v3.24.2
DESCRIPTION OF BUSINESS (Details Narrative)
12 Months Ended
Dec. 31, 2023
US [Member]  
Description Of Business [Line Items]  
Orphan drug designation provides marketing exclusivity period 7 years